RIO DE JANEIRO, BRAZIL - The Covid-19 vaccine developed by the Chinese National Pharmaceutical Group, state-owned and known as Sinopharm, may be ready for distribution later this year. The announcement was made by Sinopharm CEO Liu Jingzhen in an interview with Chinese state television CCTV.
According to Jingzhen, clinical trials began last week in Abu Dhabi, capital of the United Arab Emirates, and are expected to be completed in approximately three months, paving the way for market delivery by the end of 2020.
However, World Health Organization Executive Director Michael Ryan on Wednesday ruled out the prospect of a . . .